Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery

Spiralling research costs combined with urgent pressures from the Coronavirus 2019 (COVID-19) pandemic and the consequences of climate disruption are forcing changes in drug discovery. Increasing the predictive power of in vitro human assays and using them earlier in discovery would refocus resource...

Descripción completa

Detalles Bibliográficos
Autores principales: Treherne, J. Mark, Langley, Gillian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129828/
https://www.ncbi.nlm.nih.gov/pubmed/34015541
http://dx.doi.org/10.1016/j.drudis.2021.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129828/
https://www.ncbi.nlm.nih.gov/pubmed/34015541
http://dx.doi.org/10.1016/j.drudis.2021.05.001

Ejemplares similares